Ceva-Phylaxia turns out 50 bln poultry vaccines
Hungary-based and French-owned veterinary company Ceva-Phylaxia marked the production of its 50-billionth dose of poultry vaccine at a ceremony today. Poultry vaccines make up 80% of the company's output.
State secretary Péter Szijjártó noted that the company Phylaxia had been established more than a hundred years ago in Hungary and the Hungarian unit is currently Ceva's biggest research and development center.
Ceva-Phylaxia had revenue of €50 mln last year, said company zone director László Máté. Exports accounted for €40 mln of the total, he added.
Lenders' Home Loan Outlays at HUF 344 bln in H2 2023
Gov't Awards HUF 6.5 bln of Subsidies to SMEs in Underdevelo...
Hungary's Largest ESG Consultancy Formed by Merger of EY, De...
Hungary Launches HUF 15 bln Tourism Sector Support Program
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
